Cargando…
A New Versatile Platform for Assessment of Improved Cardiac Performance in Human-Engineered Heart Tissues
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human in vitro models for studying heart disease and for drug safety screening. Nevertheless, their associated immaturity relative to the adult myocardium limits their utility in cardiac research. In this s...
Autores principales: | Ribeiro, Marcelo C., Rivera-Arbeláez, José M., Cofiño-Fabres, Carla, Schwach, Verena, Slaats, Rolf H., ten Den, Simone A., Vermeul, Kim, van den Berg, Albert, Pérez-Pomares, José M, Segerink, Loes I., Guadix, Juan A., Passier, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877418/ https://www.ncbi.nlm.nih.gov/pubmed/35207702 http://dx.doi.org/10.3390/jpm12020214 |
Ejemplares similares
-
Contractility analysis of human engineered 3D heart tissues by an automatic tracking technique using a standalone application
por: Rivera-Arbeláez, José M., et al.
Publicado: (2022) -
Automated assessment of human engineered heart tissues using deep learning and template matching for segmentation and tracking
por: Rivera‐Arbeláez, José M., et al.
Publicado: (2023) -
Improved Atrial Differentiation of Human Pluripotent Stem Cells by Activation of Retinoic Acid Receptor Alpha (RARα)
por: Schwach, Verena, et al.
Publicado: (2022) -
Towards Improved Human In Vitro Models for Cardiac Arrhythmia: Disease Mechanisms, Treatment, and Models of Atrial Fibrillation
por: Cofiño-Fabres, Carla, et al.
Publicado: (2023) -
Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity
por: Schwach, Verena, et al.
Publicado: (2020)